Back to search

National and Kapodistrian University of Athens

Ο ρόλος του λόγου της αγγειοποιητίνης-1/αγγειοποιητίνη-2 στη ρύθμιση της επαγόμενης από τον VEGF αγγειακής διαπερατότητας σε καπνιστές ασθματικού και ασθενείς με επίμονο άσθμα, ανθιστάμενο στη θεραπεία

Abstract

dc:description

Background: Airway and vascular remodeling may play a prominent role in the clinical severity of Severe Refractory Asthma (SRA) as well as in asthmatic patients who smoke. Angiopoietin-1 (Ang-1), is an essential mediator of angiogenesis by establishing vascular integrity, whereas angiopoietin-2 (Ang-2) acts as its natural inhibitor. Objective: We aimed to determine the levels of angiopoietins in sputum supernatants of both patients with SRA and patients with asthma who smoke and to investigate possible associations with mediators and cells involved in both the inflammatory and the vascular remodeling process. Methods: Thirty-eight patients with SRA, 35 patients with moderate asthma and 20 healthy subjects were studied. For the asthmatic patients who smoke subgroup analysis, 87 patients with asthma (42 smokers) and 28 healthy subjects (14 smokers) were studied. All subjects underwent lung function tests, bronchial hyperresponsiveness assessment and sputum induction for cell count identification and Ang-1, Ang-2, VEGF, TGF-β1, Cys-LTs, MMP-2, IL-13, ECP, and IL-8 measurement in supernatants. Airway vascular permeability (AVP) index was also assessed. Results: Ang-1 and Ang-2 levels were significantly elevated in patients with SRA compared to patients with moderate asthma and control subjects [median, interquartile ranges ng/ml 30 (17-39) vs. 7.5 (5-11) vs. 4.7 (3.8-5.9) and pg/ml 506 (400-700) vs 190 (146-236) vs 96 (89-120) respectively, p<0.001]. Regression analysis showed a significant positive association between Ang-2 and AVP index, MMP-2, Ang-1 and VEGF in SRA. A weak association was also observed between Ang-1 and sputum eosinophils % in SRA. In patients with smoking asthma, Ang-1 and Ang-2 levels were significantly higher compared to patients with non-smoking asthma and healthy subjects, either smokers or non-smokers [median, interquartile ranges 24 (13-37) vs. 10 (7-14) vs. 5.3 (3.7-6.5) vs 4.6 (3.8-5.7) respectively, p<0.001 και 168 (132-203) vs 124 (82-152) vs 94 (78-113) vs 100 (96-108) respectively, p<0.001]. Regression analysis showed a significant positive association for Ang-2 with AVP index and VEGF in smoking asthma. A negative association was observed between Ang-1 and AVP index, MMP-2, VEGF and sputum neutrophils in smoking asthma. Conclusion: Our results indicate that both angiopoietins’ levels are higher in SRA compared to moderate asthma and healthy subjects. In SRA, Ang-2 is associated with mediators involved in both the inflammatory and the vascular remodeling process. Our results further indicate that both angiopoietins’ levels are higher in smoking asthma compared to non-smoking asthma and healthy subjects pointing towards a contribution of smoking through these mediators in the asthmatic angiogenesis process.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2013

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Tseliou, Eleni
  • Τσέλιου, Ελένη

Subjects

dc:subject × 18

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/29397

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Tseliou, Eleni; Τσέλιου, Ελένη. Ο ρόλος του λόγου της αγγειοποιητίνης-1/αγγειοποιητίνη-2 στη ρύθμιση της επαγόμενης από τον VEGF αγγειακής διαπερατότητας σε καπνιστές ασθματικού και ασθενείς με επίμονο άσθμα, ανθιστάμενο στη θεραπεία. National and Kapodistrian University of Athens, 2013. http://hdl.handle.net/10442/hedi/29397